doi: 10.1002/med.21754 7
Are there any exceptions where compounding will still be allowed
Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patientsa randomized placebo-controlled trial
D., Turley, D
Young: Particularly after, like, a drug treatment, is gonna be fat instead of muscle mass because, obviously, right, like, maybe with physical exercise, youre still maintaining those good behaviors a little bit more with exercising more regularly, or same with eating patternsmaybe youre still kind of, like, eating a little bit better than you were before, even if you fully stop a diet or, like, an intensive training regimen for exercise
CalogeroAEFioreMGiaconeFAltomareMAseroPLeddaCet al